A European study evaluating how public investment in innovative medicines impacts broader socioeconomic outcomes has been launched in Ireland. Conducted by the WifOR Institute in partnership with Roche, the report, "The Value of Investing in Innovative Medicines Across Europe," was officially launched at an event hosted at the Embassy of Switzerland in Ireland.
:quality(90)/)